U
Unicycive Therapeutics, Inc. (UNCY)
NCM – Real vaqt narxi. Valyuta: USD
7.13
-1.08 (-13.15%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
7.36
+0.23 (3.29%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
7.13
-1.08 (-13.15%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
7.36
+0.23 (3.29%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Unicycive Therapeutics, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, Qo'shma Shtatlarda buyrak kasalliklarini davolash uchun terapiyalarni aniqlaydi, ishlab chiqadi va tijoratlashtiradi. U dializdagi surunkali buyrak kasalligi bo'lgan bemorlarda giperfosfatemiya davolash uchun mo'ljallangan lantan asosidagi fosfat bog'lovchi vosita bo'lgan oksilantan karbonatni ishlab chiqadi; va o'tkir buyrak shikastlanishini davolash uchun I fazali klinik sinovda va surunkali buyrak kasalligini davolash uchun preklinik bosqichda bo'lgan nikotinamid ester hosilasi va selektiv ATPga sezgir mitoxondriyal kaliy kanal aktivatori UNI-494ni ishlab chiqadi. Kompaniya 2016 yilda tashkil etilgan va shtab-kvartirasi Mountain View, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Pramod Gupta Ph.D. | Executive Vice President of Pharmaceutical and Business Operations |
| Mr. Douglas Jermasek M.B.A. | Executive Vice President of Corporate Strategy |
| Mr. John W. Townsend CPA | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-22 | 8-K | ea0295382-8k_unicycive.htm |
| 2026-06-05 | S-3 | ea0291789-s3_unicycive.htm |
| 2026-06-05 | 8-K | ea0291976-8k_unicycive.htm |
| 2026-05-12 | 8-K | ea0290277-8k_unicycive.htm |
| 2026-05-12 | 10-Q | ea0289336-10q_unicycive.htm |
| 2026-05-06 | S-8 | ea0288752-s8_unicycive.htm |
| 2026-04-06 | 8-K | ea0285174-8k_unicycive.htm |
| 2026-03-30 | 8-K | ea0283942-8k_unicycive.htm |
| 2026-03-30 | 10-K | ea0281982-10k_unicycive.htm |
| 2025-11-14 | 8-K | ea0265675-8k_unicycive.htm |